Selective inhibition of the chemokine receptor CCR1 by the non-peptide antagonist BX471 provides evidence for anti-fibrotic effects of CCR1 in liver - Weber, S; Hall, R; Adrian di Bondi, I; Mahler, M; Haskell, C; Lammert, F; Grünhage, F (Zeitschrift für Gastroenterologie, 2010)